Loma Linda, CA1 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Loma Linda, CA

Find 1 actively recruiting duchenne muscular dystrophy clinical trials in Loma Linda, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
250
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Loma Linda

About Duchenne Muscular Dystrophy Clinical Trials in Loma Linda

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 1 duchenne muscular dystrophy clinical trials recruiting participants in Loma Linda, CA. These studies are seeking a combined 250 participants. Research is being sponsored by Catalyst Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Loma Linda — FAQ

Are there duchenne muscular dystrophy clinical trials in Loma Linda?

Yes, there are 1 duchenne muscular dystrophy clinical trials currently recruiting in Loma Linda, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 1 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated September 2, 2026 from ClinicalTrials.gov